sh-Oligopeptide-1 is a single chain recombinant human peptide, produced by fermentation in E.
- Límite en Corea
- 0.001%
Cuánto contienen realmente los productos
46 productos indican la cantidadmediana 0.000005%
- menos de 0,01% 46
- 0,01–0,1% 0
- 0,1–1% 0
- 1% o más 0
Las cantidades suelen indicarlas los productos que llevan el ingrediente en el nombre, así que pueden inclinarse hacia cantidades simbólicas.
De los productos que lo contienen, 85 lo listan antes de la línea del 1% y 171 después (normalmente 1% o menos).
Productos que contienen este ingrediente
12 de 253 confirmados · primero los que más probablemente lo contienen en cantidad suficiente · Ver los 253
EASYDEWEASYDEW Topical MTS Shot Ampoule0.001% indicado
Cos De BAHAES Serum0.0005% indicado
EASYDEWDaewoong Pharmaceutical EASYDEW Dark Spot Ampoule 12ml0.00015% indicado
RIREEGF Dipanthen Repair Eye Cream0.00001% indicado
RIREEGF Peplink Eye Cream0.00001% indicado
RIREEGF Midfit Lifting Ampoule0.00001% indicado
RIREEGF Dipanthen Repair Cream0.00001% indicado
RIREEGF Dipanthen Repair Cream0.00001% indicado
SidmoolDual EGF Device Gel0.000005% indicado
MEDIPEELMEDIPEEL EGF Scaling Moisture Foot Shampoo 200ml0.0000001% indicado
TENZEROTENZERO Age Solution Ampoule0.00000001% indicado
TENZEROTENZERO Age Solution Cream0.00000001% indicado
Definición
sh-Oligopeptide-1 is a single chain recombinant human peptide, produced by fermentation in E. coli. The starting gene is synthesized to be identical to the human gene which codes for Epidermal Growth Factor. It contains a maximum of 53 amino acids which may contain disulfide bonds and/or sugar. The protein consists of the proper sequence of the standard amino acids
Funciones cosméticas
Aspectos a tener en cuenta
EGF is generally safe and well tolerated in topical formulations. It is suitable for all skin types, including sensitive and aging skin. Proper formulation ensures stability and bioavailability to maximize benefits without irritation.
Referencia de uso
EGF is a naturally occurring protein that binds to epidermal growth factor receptors (EGFR) on skin cells, initiating signaling cascades that stimulate cellular proliferation, migration, and differentiation. This accelerates epidermal turnover, promotes dermal fibroblast activation, and increases synthesis of collagen and elastin—key proteins for skin firmness, elasticity, and texture. EGF facilitates wound healing and tissue regeneration by promoting new cell growth and reducing scarring. It also improves skin hydration and barrier function, while reducing fine lines, wrinkles, hyperpigmentation, and skin sagging. EGF's ability to activate key growth pathways contributes to its effectiveness in rejuvenating aging skin and enhancing overall skin resilience.
Referencias de seguridad y regulación
Corea del Sur
- Concentración máxima : 0.001%
Fuente: Información regulatoria cosmética del MFDS (Corea)
Other restriction: ban substances that deplete the ozone layer
Más datos: nombres, identificadores, propiedades, ensayos y literatura
Nombres y definiciones oficiales
Nombre de etiquetado de la JCIA 合成ヒト遺伝子組換オリゴペプチド-1: 本品は、大腸菌 E. coli によって産生させた単鎖の合成ヒトペプチドである。出発遺伝子は、上皮成長因子のコードを持ち、宿主が使用できるようにしたヒト遺伝子の合成複製物であり、ジスルフィド結合と糖鎖付加の両方またはいずれか一方を含む最大で1207個のアミノ酸からなり、そのタンパク質は固有のアミノ酸配列を持つ。
Nombres e identificadores
Literatura relacionada
- Therapy of secondary cutaneous toxicity as a result of radioterapic treatment, with a sH oligopeptide-1 cream based (epidermal growth factor-egf): a pilot study · 2018
- Topical application of sh-oligopeptide-1 and clinical trials with cosmetic preparations: risk or fraud? · 2023
- Update on the Research of an Emulgel for the Effective Treatment of Atopic Dermatitis: Clinical Investigation in Children · 2025
- Microencapsulation, Cream Development, and Controlled Clinical Study of an Upcycled Polyphenolic Extract Combined with sh-Oligopeptide-1 · 2024
- A pre-market interventional, single-arm clinical investigation of a new topical lotion based on hyaluronic acid and peptides, EGYFILTM, for the treatment of pain and stiffness in soft tissues · 2023